Obtaining high resolution structures along the Nrf2 pathway, deepening understanding of Nrf2 crosstalk with the transcriptional machinery, and characterisation of the cell death programs would, hopefully, allow more targeted cancer therapies. This evidence concerns the gene NFE2L2 and cancer.